ENDRA is focused on early detection of liver disease. TAEUS is a new, proprietary way to measure fat in the liver that is now CE-marked for sale in Europe. The technology is non-invasive and costs 50x less than MRI.
Endra Life Sciences Inc updates its merger agreement and warrant terms. The company adjusts financial and structural details to reflect new conditions or investor demands.
ASP Isotopes files an S-4 registration statement for its planned merger with ENDRA Life Sciences. The filing marks a formal step toward combining the two companies, though details on the transaction structure or timeline remain undisclosed.
ASP Isotopes proposes merging Noble Africa with ENDRA Life Sciences to create a Nasdaq-listed company focused on helium production. The deal includes a concurrent $50 million private placement to fund operations. Noble Africa targets expansion through Renergen’s Virginia Gas Project as its core helium asset.
